# CNTNAP4

## Overview
CNTNAP4, or contactin-associated protein-like 4, is a gene that encodes a member of the neurexin superfamily, which is integral to the nervous system's synaptic architecture. The protein product of CNTNAP4 is a transmembrane protein that plays a pivotal role in neuronal communication, particularly within dopaminergic and GABAergic synapses. It is primarily localized presynaptically, where it influences synaptic transmission and neuron-neuron communication by modulating neurotransmitter release. This modulation is crucial for maintaining synaptic stability and proper neuronal function, impacting processes such as motor activity and synaptic plasticity. CNTNAP4's involvement in neuroactive ligand-receptor interactions and calcium signaling pathways underscores its significance in mitochondrial function and neuronal health. Alterations in CNTNAP4 expression have been associated with various neurological disorders, including epilepsy, autism spectrum disorders, and Parkinson's disease, highlighting its potential as a therapeutic target (Zhang2020CNTNAP4; Karayannis2014Cntnap4).

## Function
CNTNAP4, a member of the neurexin superfamily, plays a critical role in neuronal communication, particularly in dopaminergic and GABAergic synapses. In healthy cells, CNTNAP4 is localized presynaptically and is involved in synaptic function, affecting synaptic transmission and neuron-neuron communication. It is essential for maintaining dopaminergic synaptic transmission and mitochondrial function, which are crucial for normal motor function and neuronal health (Zhang2020CNTNAP4).

CNTNAP4 is highly enriched in developing interneurons and is associated with presynaptic proteins important for inhibitory synapses. It modulates synaptic transmission by attenuating dopamine release through a presynaptic mechanism, which is vital for the proper functioning of GABAergic and dopaminergic systems (Karayannis2014Cntnap4). The gene also influences GABAergic synaptic transmission by interacting with proteins like Mint1 and calcium/calmodulin-dependent serine protein kinase, which are important for synaptic function (Zhang2020CNTNAP4).

CNTNAP4 is involved in neuroactive ligand-receptor interactions and calcium signaling pathways, which are crucial for mitochondrial ATP generation and neuronal activity. Its role in calcium signaling is linked to dopamine receptor D5 signaling, modulating motor activity and synaptic plasticity (Zhang2020CNTNAP4).

## Clinical Significance
Alterations in the CNTNAP4 gene have been linked to several neurological disorders, including epilepsy, autism spectrum disorders (ASDs), and Parkinson's disease. In epilepsy, particularly temporal lobe epilepsy (TLE), decreased expression of CNTNAP4 is observed in the temporal neocortex of patients and in mouse models. This reduction is associated with increased seizure susceptibility, while overexpression of CNTNAP4 reduces seizure activity, suggesting a protective role against epilepsy development (Shangguan2017CNTNAP4). The gene's involvement in inhibitory synaptic functions, particularly through GABAA receptor regulation, is crucial in this context (Shangguan2017CNTNAP4).

CNTNAP4 is also implicated in autism, with knock-out mice displaying autistic-like behaviors and epileptic seizures. The structural similarity between CNTNAP4 and CNTNAP2, another gene associated with ASDs, suggests a potential common developmental mechanism between epilepsy and autism (Shangguan2017CNTNAP4).

In Parkinson's disease, CNTNAP4 deficiency in dopaminergic neurons is linked to parkinsonian phenotypes. Knockout models show exacerbated α-synuclein pathology and motor dysfunction, mediated through astrocyte-microglia crosstalk involving the C3-C3aR signaling pathway. This deficiency is associated with mitochondrial dysfunction and ferroptosis, contributing to dopaminergic neuronal death (Zhang2020CNTNAP4; Zhang2023Cntnap4).

## Interactions
CNTNAP4, also known as contactin-associated protein-like 4, is involved in various interactions within the nervous system. It is a member of the neurexin superfamily and plays a significant role in synaptic transmission, particularly in GABAergic and dopaminergic neurons. CNTNAP4 interacts with presynaptic proteins such as Mint1 and calcium/calmodulin-dependent serine protein kinase, which are crucial for synaptic function and GABAergic synaptic transmission (Zhang2020CNTNAP4). It also binds to CASK, a PDZ domain-containing protein, which is part of the CASK/Lin2-Veli/Lin7-Mint1/Lin10 complex, suggesting its involvement in synaptic organization and function (Spiegel2002Caspr3).

CNTNAP4 affects neuron excitability and inhibits synaptic transmission through postsynaptic GABA type-A receptors (GABAARs) by influencing GABAAR transport and membrane expression via GABAAR-associated protein (GABARAP) (Zhang2020CNTNAP4). This interaction with GABARAP is significant in regulating GABAergic transmission and may be linked to autophagy processes (Zhang2020CNTNAP4). These interactions highlight CNTNAP4's role in maintaining synaptic stability and neurotransmission, making it a potential target for therapeutic interventions in neurological disorders.


## References


[1. (Shangguan2017CNTNAP4) Yafei Shangguan, Xin Xu, Baigalimaa Ganbat, Yun Li, Wei Wang, Yong Yang, Xi Lu, Chao Du, Xin Tian, and Xuefeng Wang. Cntnap4 impacts epilepsy through gabaa receptors regulation: evidence from temporal lobe epilepsy patients and mouse models. Cerebral Cortex, 28(10):3491–3504, August 2017. URL: http://dx.doi.org/10.1093/cercor/bhx215, doi:10.1093/cercor/bhx215. This article has 22 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/cercor/bhx215)

[2. (Spiegel2002Caspr3) Ivo Spiegel, Daniela Salomon, Beat Erne, Nicole Schaeren-Wiemers, and Elior Peles. Caspr3 and caspr4, two novel members of the caspr family are expressed in the nervous system and interact with pdz domains. Molecular and Cellular Neuroscience, 20(2):283–297, June 2002. URL: http://dx.doi.org/10.1006/mcne.2002.1110, doi:10.1006/mcne.2002.1110. This article has 75 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/mcne.2002.1110)

[3. (Zhang2023Cntnap4) Wenlong Zhang, Liuyan Ding, Huaqing Chen, Mengran Zhang, Runfang Ma, Shaohui Zheng, Junwei Gong, Zhiling Zhang, Huaxi Xu, Pingyi Xu, and Yunlong Zhang. Cntnap4 partial deficiency exacerbates α-synuclein pathology through astrocyte–microglia c3-c3ar pathway. Cell Death &amp; Disease, April 2023. URL: http://dx.doi.org/10.1038/s41419-023-05807-y, doi:10.1038/s41419-023-05807-y. This article has 10 citations.](https://doi.org/10.1038/s41419-023-05807-y)

[4. (Zhang2020CNTNAP4) Wenlong Zhang, Miaomiao Zhou, Weiye Lu, Junwei Gong, Feng Gao, Yuanquan Li, Xuandong Xu, Yuwan Lin, Xiaokang Zhang, Liuyan Ding, Zhiling Zhang, Guihua Li, Xiang Chen, Xiangdong Sun, Xiaoqin Zhu, Pingyi Xu, and Yunlong Zhang. Cntnap4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes. Theranostics, 10(7):3000–3021, 2020. URL: http://dx.doi.org/10.7150/thno.40798, doi:10.7150/thno.40798. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7150/thno.40798)

[5. (Karayannis2014Cntnap4) T. Karayannis, E. Au, J. C. Patel, I. Kruglikov, S. Markx, R. Delorme, D. Héron, D. Salomon, J. Glessner, S. Restituito, A. Gordon, L. Rodriguez-Murillo, N. C. Roy, J. A. Gogos, B. Rudy, M. E. Rice, M. Karayiorgou, H. Hakonarson, B. Keren, G. Huguet, T. Bourgeron, C. Hoeffer, R. W. Tsien, E. Peles, and G. Fishell. Cntnap4 differentially contributes to gabaergic and dopaminergic synaptic transmission. Nature, 511(7508):236–240, May 2014. URL: http://dx.doi.org/10.1038/nature13248, doi:10.1038/nature13248. This article has 148 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature13248)